Quantitative and qualitative influences of tapasin on the class I peptide repertoire

Journal of Immunology

Volumn 166, Issue 2, 2001, Pages 1016-1027

  Purcell, A W ^a   Gorman, J J ^a   Garcia Peydro M ^a   Paradela, A ^a   Burrows, S R ^a   Talbo, G H ^a   Laham, N ^a   Chen Au Peh, ^a   Reynolds, E C ^a   Lopez de Castro J A ^a   McCluskey, J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CHAPERONE; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA B2705 ANTIGEN; PEPTIDE; TAPASIN; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN ISOLATION;

EID: 0035863732     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.2.1016     Document Type: Article

References (57)

1. The nature of the MHC class I peptide loading complex
2. Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP
3. 2-microglobulin, class I heavy chain conformation and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing
4. Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line 220
5. The N-terminal region of tapasin is required to stabilize the MHC class I loading complex
6. Tapasin is required for efficient peptide binding to transporter associated with antigen processing
7. Retention of empty MHC class I molecules by tapasin is essential to reconstitute antigen presentation in invertebrate cells
8. Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules
9. Setting the standards: Quality control in the secretory pathway
10. Endogenous and exogenous factors contributing to the surface expression of HLA B27 on mutant antigen presenting cells
11. Evidence for successive peptide binding and quality control stages during MHC class I assembly
12. HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loading
13. Definition and transfer of a serological epitope specific for peptide-empty forms of MHC class I
14. An extensive region of an MHC class I α2 domain loop influences interaction with the assembly complex
15. Impaired immune responses and altered peptide repertoire in tapasin-deficient mice
16. Impaired assembly yet normal trafficking of MHC class I molecules in tapasin mutant mice
17. Novel allele specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line
18. Sequence, linkage to H2-K, and function of mouse tapasin in MHC class I assembly
19. Dependence of peptide binding by MHC class I Molecules on their interaction with TAP
20. HLA-A*0201 presents TAP-dependent peptide epitopes to cytotoxic T lymphocytes in the absence of tapasin
21. Exogenous peptide ligand influences the expression and half-life of free HLA class I heavy chains ubiquitously detected at the cell surface
22. Peptide binding to empty HLA-B27 molecules of viable human cells
23. Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line 220 reveals polymorphism and alternative splicing of the tapasin gene
24. Presentation of viral antigen controlled by a gene in the major histocompatibility complex
25. Distinct functions of tapasin revealed by polymorphism in MHC class I peptide loading
26. Clonal analysis of alloreactive T cell responses against the closely related B*2705 and B*2703 subtypes: Implications for HLA-B27 association to spondyloarthropathy
27. High T cell epitope sharing between two HLA-B27 subtypes (B*2705 and B*2709) differentially associated to ankylosing spondylitis
28. Detection of fungal carbohydrate antigens by high-performance immuno-affinity chromatography using a protein A column with covalently linked immunoglobulin G
29. Identification of a graft versus host disease-associated human minor histocompatibility antigen
30. Strategies for epitope analysis using peptide synthesis
31. Characterization of pathotype-specific epitopes of Newcastle disease virus fusion glycoproteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and post-source decay sequencing
32. The same natural ligand is involved in allorecognition of multiple HLA-B27 subtypes by a single T cell clone: Role of peptide and the MHC molecule in alloreactivity
33. An improved assembly assay for peptide binding to HLA-B*2705 and H- 2K(k) class I MHC molecules
34. The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC
35. Molecular dynamics simulation of MHC-peptide complexes as a tool for predicting potential T cell epitopes
36. 2-microglobulin-free heavy chain homodimer structure
37. MHC ligands and peptide motifs: First listing
38. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C
39. Modulation at multiple anchor positions of the peptide specificity of HLA-B27 subtypes differentially associated with ankylosing spondylitis
40. Susceptibility to ankylosing spondylitis correlates with the C-terminal residue of peptides presented by various HLA-B27 subtypes
41. Identification of self peptides bound to purified HLA-B27
42. Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants: Implications for susceptibility to spondylarthropathies
43. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs
44. HLA-B27 subtype polymorphism and CTL epitope choice: Studies with EBV peptides link immunogenicity with stability of the B27:,peptide complex
45. Different MHC class I alleles compete for presentation of overlapping viral epitopes
46. Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides
47. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures
48. MHC class I molecules compete in the endoplasmic reticulum for access to transporter associated with antigen processing
49. Tapasin enhances assembly of transporters associated with antigen processing-dependent and -independent peptides with HLA-A2 and HLA-B27 expressed in insect cells
50. Genes regulating MHC class I processing of antigen
51. d molecules and of GFP-TAP1 reports on the assembly and retention of these molecules in the endoplasmic reticulum
52. Peptide-bound major histocompatibility complex class I molecules associate with tapasin before dissociation from transporter associated with antigen processing
53. Cutting edge: Adenovims E19 has two mechanisms for affecting class I MHC expression
54. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals
55. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
56. HLA-B27 presents a peptide from a polymorphic region of its own molecule with homology to proteins from arthritogenic bacteria
57. + T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis